Cargando…

Polycystic Ovary Syndrome and COVID-19: An Emerging Risk Factor

Detalles Bibliográficos
Autor principal:	Joshi, Shashank R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279055/ https://www.ncbi.nlm.nih.gov/pubmed/34316241 http://dx.doi.org/10.4103/jhrs.jhrs_79_21

Ejemplares similares

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Primary Care Screening Tool for Polycystic Ovary Syndrome: Step One in the Battle Against Non-Communicable Disease
por: Kalra, Sanjay, et al.
Publicado: (2023)

Polycystic ovarian morphology in Thai women of reproductive age with polycystic ovary syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2020)

The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: A pilot study
por: Mavropoulos, John C, et al.
Publicado: (2005)

The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome
por: Akpinar, Funda, et al.
Publicado: (2016)

Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study
por: Gill, Harmandeep, et al.
Publicado: (2012)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Polycystic ovary syndrome and risk factors for gestational diabetes
por: Mustaniemi, Sanna, et al.
Publicado: (2018)

The relationship between quality of life and coping strategies in polycystic ovary syndrome patients
por: Kolahi, Leila, et al.
Publicado: (2015)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Should Women with Polycystic Ovarian Syndrome be Prioritized to Receive the COVID Vaccine?
por: Shah, Duru
Publicado: (2021)

The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic
por: Jerzak, Małgorzata, et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Thyroid disorders and polycystic ovary syndrome: An emerging relationship
por: Singla, Rajiv, et al.
Publicado: (2015)

Anti-Nuclear Antibodies in Patients with Polycystic Ovary Syndrome before and after Laparoscopic Electrocauterization
por: Samsami Dehaghani, Alamtaj, et al.
Publicado: (2013)

Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome
por: Abazar, Elaheh, et al.
Publicado: (2015)

Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome
por: Ibáñez, Lourdes, et al.
Publicado: (2020)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
por: Pandurevic, Srdan, et al.
Publicado: (2021)

Nutrient Patterns and Risk of Polycystic Ovary Syndrome
por: Eslamian, Ghazaleh, et al.
Publicado: (2019)

Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome
por: Amin, Mutaz, et al.
Publicado: (2023)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Evidence From Men for Ovary-independent Effects of Genetic Risk Factors for Polycystic Ovary Syndrome
por: Zhu, Jia, et al.
Publicado: (2021)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Serum Soluble Glycoprotein 130 Concentration Is Inversely Related to Insulin Sensitivity in Women With Polycystic Ovary Syndrome
por: Nikolajuk, Agnieszka, et al.
Publicado: (2010)

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease
por: Blagojevic, Iva Perovic, et al.
Publicado: (2017)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Hydroalcoholic extract of flaxseed improves polycystic ovary syndrome in a rat model
por: Jelodar, Gholamali, et al.
Publicado: (2018)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?
por: Dilbaz, Berna
Publicado: (2021)

Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome
por: Gourgari, Evgenia, et al.
Publicado: (2016)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?
por: Dogan, Ozlem
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_27kko8bu9sv9qoes8umldgctai